Oncology Institute Inc (TOI)
Who owns Oncology Institute Inc (TOI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.3% of the shares are freely tradable; institutional investors hold 46.1%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 4.75 | 4,748,635 | +4.5 | 12/31/2025 |
| BlackRock Inc | 4.42 | 4,415,867 | +13.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.48 | 3,476,781 | +0.0 | 03/31/2026 |
| Deerfield Management Co | 3.36 | 3,360,052 | +0.0 | 03/31/2026 |
| Kanen Wealth Management LLC | 2.78 | 2,777,858 | -6.7 | 03/31/2026 |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 2.46 | 2,464,359 | +0.2 | 03/31/2026 |
| Balyasny Asset Management LLC | 1.83 | 1,826,370 | -27.5 | 03/31/2026 |
| Geode Capital Management, LLC | 1.76 | 1,757,847 | +11.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.62 | 2,616,199 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.92 | 1,921,513 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Kaushal Mohit | Director | Other | 33,133 | 0.00 | – |
| 27. Jul 2026 | McGeorge Anne | Director | Other | 41,165 | 0.00 | – |
| 27. Jul 2026 | Pacala Mark L | Director | Other | 30,120 | 0.00 | – |
| 27. Jul 2026 | Stolper Mark | Director | Other | 31,124 | 0.00 | – |
| 27. Jul 2026 | Tzoumakas Kimberly Jo | Director | Other | 29,116 | 0.00 | – |
| 27. Jul 2026 | Hively Brad | Director | Other | 27,108 | 0.00 | – |
| 27. Jul 2026 | Johnson Karen Marie | Director | Other | 31,124 | 0.00 | – |
| 21. Jul 2026 | Chernett Jorey | 10% Owner | Buy | 18,000 | 5.27 | 94,860 |
| 14. Jul 2026 | Podnos Yale | Chief Medical Officer | Sell | 5,478 | 6.35 | 34,785 |
| 14. Jul 2026 | Podnos Yale | Chief Medical Officer | Other | 5,478 | 2.00 | 10,956 |
| 14. Jul 2026 | Podnos Yale | Chief Medical Officer | Sell | 17,974 | 6.43 | 115,555 |
| 14. Jul 2026 | Podnos Yale | Chief Medical Officer | Other | 17,974 | 1.87 | 33,611 |
| 10. Jul 2026 | Chernett Jorey | 10% Owner | Buy | 15,000 | 5.85 | 87,750 |
| 7. Jul 2026 | Tzoumakas Kimberly Jo | Director | Other | 17,185 | 0.00 | – |
| 7. Jul 2026 | Stolper Mark | Director | Other | 25,833 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.